myfortic 360 mg tabletki dojelitowe
novartis poland sp. z o.o. - acidum mycophenolicum - tabletki dojelitowe - 360 mg
gammanorm 165 mg/ml roztwór do wstrzykiwań
octapharma (ip) sprl - immunoglobulinum humanum normale - roztwór do wstrzykiwań - 165 mg/ml
myfortic 180 mg tabletki dojelitowe
novartis poland sp. z o.o. - acidum mycophenolicum - tabletki dojelitowe - 180 mg
marelim 360 mg tabletki dojelitowe
accord healthcare polska sp. z o.o. - acidum mycophenolicum - tabletki dojelitowe - 360 mg
cuvitru 200 mg/ml roztwór do wstrzykiwań
takeda pharma sp. z o.o. - immunoglobulina ludzka normalna - roztwór do wstrzykiwań - 200 mg/ml
marelim 180 mg tabletki dojelitowe
accord healthcare polska sp. z o.o. - acidum mycophenolicum - tabletki dojelitowe - 180 mg
mycofit 500 mg tabletki powlekane
accord healthcare polska sp. z o.o. - mycophenolas mofetil - tabletki powlekane - 500 mg
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - Środki przeciwnowotworowe - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
mycofit 250 mg kapsułki twarde
accord healthcare polska sp. z o.o. - mycophenolas mofetil - kapsułki twarde - 250 mg
mykofenolan mofetylu accord 500 mg proszek do sporządzania koncentratu roztworu do infuzji
accord healthcare polska sp. z o.o. - mycophenolas mofetil - proszek do sporządzania koncentratu roztworu do infuzji - 500 mg